Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for Patients With Advanced Non-small Cell Lung Cancer

NCT03525782 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Guangdong Pharmaceutical University as lead sponsor.

NCT NCT03525782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03525782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for Patients With Advanced Non-small Cell Lung Cancer
Lead sponsor
The First Affiliated Hospital of Guangdong Pharmaceutical University
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 1, 2018
Completion date
January 31, 2022
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasm malignant, non-small cell lung cancer